These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8673091)

  • 1. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
    Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
    Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons.
    Pages S; Caux V; Stoppa-Lyonnet D; Tosi M
    Br J Cancer; 2001 Feb; 84(4):482-8. PubMed ID: 11207042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
    Tavtigian SV; Simard J; Rommens J; Couch F; Shattuck-Eidens D; Neuhausen S; Merajver S; Thorlacius S; Offit K; Stoppa-Lyonnet D; Belanger C; Bell R; Berry S; Bogden R; Chen Q; Davis T; Dumont M; Frye C; Hattier T; Jammulapati S; Janecki T; Jiang P; Kehrer R; Leblanc JF; Mitchell JT; McArthur-Morrison J; Nguyen K; Peng Y; Samson C; Schroeder M; Snyder SC; Steele L; Stringfellow M; Stroup C; Swedlund B; Swense J; Teng D; Thomas A; Tran T; Tranchant M; Weaver-Feldhaus J; Wong AK; Shizuya H; Eyfjord JE; Cannon-Albright L; Tranchant M; Labrie F; Skolnick MH; Weber B; Kamb A; Goldgar DE
    Nat Genet; 1996 Mar; 12(3):333-7. PubMed ID: 8589730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
    Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.
    Gayther SA; Mangion J; Russell P; Seal S; Barfoot R; Ponder BA; Stratton MR; Easton D
    Nat Genet; 1997 Jan; 15(1):103-5. PubMed ID: 8988179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
    Phelan CM; Lancaster JM; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher MC; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod SA; Futreal PA
    Nat Genet; 1996 May; 13(1):120-2. PubMed ID: 8673090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
    Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
    Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
    Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
    Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
    Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the BRCA2 gene in ovarian carcinomas.
    Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J
    Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.
    Ligtenberg MJ; Hogervorst FB; Willems HW; Arts PJ; Brink G; Hageman S; Bosgoed EA; Van der Looij E; Rookus MA; Devilee P; Vos EM; Wigbout G; Struycken PM; Menko FH; Rutgers EJ; Hoefsloot EH; Mariman EC; Brunner HG; Van 't Veer LJ
    Br J Cancer; 1999 Mar; 79(9-10):1475-8. PubMed ID: 10188893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
    Hadjisavvas A; Charalambous E; Adamou A; Christodoulou CG; Kyriacou K
    Hum Mutat; 2003 Feb; 21(2):171. PubMed ID: 12552570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB; Boyd AA; Volcik K; Richards CS
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
    Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.